Abstract
Analysis of HER2 status of the tumor and expression of mTOR, AMPK showed a decrease in mTOR mRNA level in HER2+ tumors in comparison with HER- status. The appearance of PD-L1+ transformed cells in the tumor was associated with increased expression of the LC3B gene and elevated content of the corresponding protein measured after treatment.
Keywords:
HER2 tumor status; LC3B; PD-L1 tumor status; gastric cancer.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.
MeSH terms
-
AMP-Activated Protein Kinases / genetics
-
AMP-Activated Protein Kinases / metabolism
-
Adenocarcinoma* / diagnosis
-
Adenocarcinoma* / drug therapy
-
Adenocarcinoma* / genetics
-
Adenocarcinoma* / metabolism
-
Antineoplastic Agents / therapeutic use
-
B7-H1 Antigen / genetics
-
B7-H1 Antigen / metabolism
-
Biomarkers, Pharmacological / metabolism
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Microtubule-Associated Proteins* / genetics
-
Microtubule-Associated Proteins* / metabolism
-
Prognosis
-
Receptor, ErbB-2 / genetics
-
Receptor, ErbB-2 / metabolism
-
Stomach Neoplasms* / diagnosis
-
Stomach Neoplasms* / drug therapy
-
Stomach Neoplasms* / genetics
-
Stomach Neoplasms* / metabolism
-
TOR Serine-Threonine Kinases / genetics
-
TOR Serine-Threonine Kinases / metabolism
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
B7-H1 Antigen
-
Biomarkers, Pharmacological
-
Biomarkers, Tumor
-
CD274 protein, human
-
MAP1LC3B protein, human
-
Microtubule-Associated Proteins
-
MTOR protein, human
-
Receptor, ErbB-2
-
TOR Serine-Threonine Kinases
-
AMP-Activated Protein Kinases